Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Pulmatrix, Inc. PULM

Full chart Compare

Set alert

1.31 USD -0.04 (-2.96%)

At closeNov 11, 2026, 4:00 PM EST

1.33 +0.02 +1.53%

After hours · Nov 11, 4:00 PM ET

1.29 Day range 1.37

1.06 52-week range 4.98

YTD: -41.26%
1 year: -73.05%

News

2 days ago globenewswire.com Eos SENOLYTIX's PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference Data to highlight PTC-2105's attenuation of terminal lean-mass decline and semaglutide-associated lean-mass loss in aged mice PTC-2105 is Eos's lead clinical candidate in development for elderly…
2 weeks ago benzinga.com Eos SENOLYTIX Presents New Preclinical Survival, Healthspan, Mechanism-Of-Action Data For Its PTC-2105 Candidate At 17th World Congress On Targeting Mitochondria 2026 Eos SENOLYTIX, Inc. ("Eos" or the "Company") a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today presented new preclinical survival, healthspan and